Previous close | 487.79 |
Open | 486.97 |
Bid | 441.00 |
Ask | 449.90 |
Strike | 470.00 |
Expiry date | 2025-12-19 |
Day's range | 486.97 - 487.79 |
Contract range | N/A |
Volume | |
Open interest | 9 |
Eli Lilly (LLY) concluded the recent trading session at $887.16, signifying a +0.18% move from its prior day's close.
FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 diabetes drug Mounjaro, implying the company can now supply enough doses to meet current demand. What does that mean for the marketplace?